Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

10 clinical studies listed.

Filters:

Fractures

Tundra lists 10 Fractures clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07936279

Geriatric Hip Fracture mFI-5 for Postoperative ICU Need and 30 Day Mortality

This prospective, observational, single-center study aims to evaluate the predictive value of the Modified Frailty Index-5 (mFI-5) score on postoperative intensive care unit (ICU) admission requirements and 30-day mortality in geriatric patients undergoing hip fracture surgery. Patients aged 65 and older presenting with a hip fracture will be evaluated preoperatively using the mFI-5 scoring system (assessing diabetes, hypertension, COPD, congestive heart failure, and functional dependence). Intraoperative hemodynamic data, anesthesia type, and transfusion requirements will be documented. Postoperative ICU admission, total hospital stay, and 30-day survival status will be recorded to assess the prognostic capability of preoperative frailty levels.

Gender: All

Ages: 65 Years - 70 Years

Updated: 2026-11-13

1 state

Hip
Fractures
Frailty
+1
NOT YET RECRUITING

NCT07924722

Local Iloprost Therapy to Promote Bone Healing in High Risk Fractures

What is this study about? When a bone breaks, it usually heals within a few months. In some people, however, the bone does not heal properly (a "non-union"), which can mean ongoing pain, more surgery, and a longer time off work. This study tests whether a single, local treatment with a medicine called iloprost, given right at the fracture site, can help bones heal better in people who are more likely to have healing problems. Who can take part? Patients who need surgery to fix a broken bone and who are at higher risk of poor healing. A blood test before surgery measures a certain type of immune cell (CD8+ TEMRA cells). A high level (38% or more) indicates a higher risk. About 533 people will be tested to find 60 participants. What happens during the study: Surgery: Everyone receives the standard operation to fix the bone. During surgery, a thin, soft tube (catheter) is placed near the fracture, similar to those routinely used to deliver pain medication to wounds. Groups: Participants are assigned by chance (like a coin toss) to one of two equal groups: Group 1: iloprost through the tube for 24 hours Group 2: a harmless salt-water solution (placebo) for 24 hours Timing: In both groups, salt water runs for the first 24 hours after surgery. The next 24 hours bring either iloprost or placebo. Treatment lasts 48 hours in total. Blinding: Participants, doctors, nurses, and the people who assess the results do not know who receives which treatment. Only the pharmacy staff who prepare the infusions know, and they are not involved in patient care. This keeps the results fair and unbiased. What happens afterwards? Participants are followed for about one year (52 weeks), with clinic visits at weeks 6, 18, and 36 and a phone call at week 52. How will we know if it worked? The main question is whether the bone has healed by week 18, as seen on a CT scan. The study also looks at bone healing at week 36, pain, physical function, quality of life, return to work, and changes in immune cells and blood markers, which help explain how the treatment works. How is safety monitored? All side effects are recorded and compared between the two groups to see how safe and well tolerated the treatment is. Why does this matter? Currently, there are few ways to prevent healing problems before they occur. If the treatment works, it could help patients heal faster and avoid further operations. This is an early-stage (phase II) study at a single center. It can show whether the treatment is promising, but it cannot yet prove that it should become standard care.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2026-11-09

Nonunion Bone Fracture
Fractures Ununited
Fractures
COMPLETED

NCT07791095

REDUCTION ACCURACY IN NASO-ORBITO-ETHMOIDAL FRACTURES AFTER VIRTUAL REDUCTION AND FIXATION USING PRE-ADAPTED MINIPLATES

This study aims to assess the reduction accuracy of Naso-orbito-ethmoidal (NOE) fractures using pre-adapted titanium miniplates based on a virtually reduced 3D model.

Gender: All

Ages: 18 Years - Any

Updated: 2026-10-21

Naso-Orbito-Ethmoidal
Fractures
ACTIVE NOT RECRUITING

NCT07401953

Fracture Risk in Living Kidney Donors

This study will be a population-based, matched retrospective cohort study using linked administrative healthcare databases from Ontario, Alberta, and British Columbia to evaluate the long-term risk of fractures among living kidney donors compared with a healthy cohort of nondonors. Living kidney donors who donated between 1992 and 2024 will be included and matched 1:10 to a carefully selected population of nondonors based on key demographic and clinical characteristics. The primary outcome is a composite of incident hip, femoral shaft, humeral, wrist/forearm, and pelvic fractures. Secondary outcomes will examine each fracture site separately. The results will provide evidence to inform clinical guidelines, support informed decision-making for potential donors and recipients, and guide counselling by transplant clinicians.

Gender: All

Ages: 18 Years - 105 Years

Updated: 2026-09-14

Living Kidney Donor
Living Kidney Donation
Fractures
+2
TERMINATED

NCT03367169

Surgery of the Pilon Fractures

The assessment consists in comparing the osteosynthesis plate with minimally invasive technique versus open reduction and internal fixation. The aim of study is to compare (period of bandage, efficacy, safety), these two types of surgical technique by using a prospective, randomized analysis.

Gender: All

Ages: 18 Years - Any

Updated: 2026-08-05

Pilon Fractures
Fractures
Bone
+1
RECRUITING

NCT06624969

Virtual Reality in Reducing Acute Orthopedic Pain

The primary aim of this research is to show that a virtual reality (VR) service line is feasible and can sustain itself with the ability to take care of patients. Additionally, the investigators aim to learn about the limitations of a service line and provide a pathway for future improvements in building a VR service line that is optimally aligned with the user's needs. Secondary aims are to evaluate the clinical aspects of the patient's outcomes including length of stay, morphine equivalents in pain medicine required during the hospital stay, and user experiences.

Gender: All

Ages: 18 Years - Any

Updated: 2026-05-05

1 state

Fractures
COMPLETED

NCT01704859

VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers

The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among participants in VITAL and will examine (1) whether vitamin D reduces incident total, non-vertebral fractures, and hip fractures and (2) whether this reduction is modified by vitamin D levels

Gender: All

Ages: 50 Years - Any

Updated: 2026-04-27

1 state

Fractures
ACTIVE NOT RECRUITING

NCT04573946

VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)

Vitamin D supplements are widely promoted for bone health. Both vitamin D and vitamin K are important for deposition of calcium in bone, but little is known about the relationship of vitamin K status and bone health.

Gender: All

Ages: 50 Years - Any

Updated: 2026-04-27

1 state

Bone Density
Bone Health
Fractures
NOT YET RECRUITING

NCT07063797

Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes

This study will conduct a randomized controlled trial targeting patients with type 2 diabetes and a high risk of fractures. The aim is to evaluate the intervention effect of denosumab combined with edilossobulin on patients with a high risk of osteoporotic fractures due to type 2 diabetes, as well as its impact on bone density, bone turnover indicators, the risk of new fractures, and the risk of hypocalcemia. This will provide scientific evidence for clinical diagnosis and treatment, and offer important clinical research evidence for formulating national health policies.

Gender: All

Ages: 50 Years - Any

Updated: 2026-01-21

1 state

Type 2 Diabetes
Osteoporosis
Fractures
ACTIVE NOT RECRUITING

NCT00633828

Influence of External Factors on Skeletal Growth in Youth

Objective: Prospective study regulation in bone mass, size, architecture, cortical, trabecular bone, soft tissues and risk factors for cardiovascular disease at growth. Determine regulation by environmental factors. Evaluate how training affects the skeleton, soft tissues and cardiovascular risk factors during growth Material/Methods: (i) 500 children in one RCT´s with or without intervention with physical activity (daily scholl physical education) from school start to college. Annual evaluations Importance: The investigators provide increased understanding of the pathophysiology of osteoporosis by determine the mineralization, size- and architecture development during growth and adulthood. Evaluate if intervention program with exercise increase bone strength, muscle mass and reduce fatness and risk factor for cardiovascular disease. Background: Skeletal growth and the age related bone loss determine who will get osteoporosis (and fractures), but not only bone mass, also skeletal architecture and bone quality influence bone strength. Regulation of the traits differs where hormones, genetics and environmental factors continuously influence the development with different effect during different ages. It is thus imperative to determine the regulators of the traits and evaluate if these can be modified during growth. Aim: Study regulation of bone mass, size, architecture, cortical, trabecular, axial and appendicular bone and soft tissue during growth and aging; evaluate risk factors for cardiovascular disease; determine importance of environmental factors and hereditary factors. Study Design/Method Bunkeflo Cohort: Prospective, controlled exercise intervention study annually following skeletal development in 500children from age 7. Importance: By evaluating skeletal mass/architecture separate we will increase the understanding of the pathophysiology of osteoporosis. The intervention study provide Evidence Based Information as regard the importance of physical activity during growth. The presented Strength Index, where we combine bone mass and skeletal architecture, may predict fractures better than only bone mass.

Gender: All

Ages: 6 Years - 16 Years

Updated: 2025-06-27

Fractures